PMV Pharmaceuticals, Inc. (PMVP) Misses Q3 EPS by 2c

PMV Pharmaceuticals, Inc. (NASDAQ: PMVP) reported Q3 EPS of ($0.37), $0.02 worse than the analyst estimate of ($0.35).

For earnings history and earnings-related data on PMV Pharmaceuticals, Inc. (PMVP) click here.

You May Also Be Interested In

• PG&E Corp, Edison Spike; California Assembly Won't Take Vote On Utility Wildfire Bill
• Medtronic jumps on earnings beat and raised guidance
• GDS Holdings (GDS) PT Lowered to $51 at Raymond James